Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Zimmer Biomet Holdings Q4 Adjusted EPS $2.20 Beats $2.15 Estimate, Sales $1.94B Beat $1.93B Estimate

Author: Benzinga Newsdesk | February 08, 2024 07:32am
Zimmer Biomet Holdings (NYSE:ZBH) reported quarterly earnings of $2.20 per share which beat the analyst consensus estimate of $2.15 by 2.33 percent. This is a 17.02 percent increase over earnings of $1.88 per share from the same period last year. The company reported quarterly sales of $1.94 billion which beat the analyst consensus estimate of $1.93 billion by 0.52 percent. This is a 6.31 percent increase over sales of $1.82 billion the same period last year.

Posted In: ZBH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist